1Bezabhe WM, Chalmers L, Bereznicki LR, Peterson GM, Bimirew MA, et al. (2014) Barriers and facilitators of adherence to antiretroviral drug therapy and retention in care among adult HIV-positive patients: a qualitative study from Ethiopia. PLoS One 9: e97353.

2Alemu K, Likisa J, Alebachew M, Temesgen G, Tesfaye G, et al. (2014) Adherence to highly active antiretroviral therapy and predictors of non- adherence among pediatrics attending ambo hospital art clinic, West Ethiopia. J HIV AIDS Infect Dis 2: 1-7.

3UNAIDS/WHO (2012) Country progress report on HIV/AIDS response 2012.

4Bangsberg DR, Hecht FM, Charlebois ED, Zolopa AR, Holodniy M, et al. (2000) Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population. AIDS 14: 357-366.

5Pan’s Global AIDS Program (2006) Anti retroviral drugs for all: obstacles to access to HIV/AIDS treatment lessons from Ethiopia, Haiti, India, Nepal and Zambia.

6Turner BJ (2002) Adherence to antiretroviral therapy by human immunodeficiency virus-infected patients. J Infect Dis 185: S143-S151.

7Taylor BS, Garduno LS, Reyes EV, Valino R, Rojas R, et al. (2011) HIV care for geographically mobile populations. Mt Sinai J Med 78: 342-351.

8Upton RL (2001) Infertility makes you invisible: gender, health and the negotiation of fertility in Northern Botswana. Journal of Southern African Studies 27: 349-362.

9Merten S, Kenter E, McKenzie O, Musheke M, Ntalasha H, et al. (2010) Patient-reported barriers and drivers of adherence to antiretrovirals in sub-Saharan Africa: a meta-ethnography. Trop Med Int Health 15: 16-33.

10Nachega JB, Stein DM, Lehman DA, Hlatshwayo D, Mothopeng R, et al. (2004) Adherence to antiretroviral therapy in HIV-infected adults in Soweto, South Africa. AIDS Res Hum Retroviruses 20: 1053-1056.

11Nsimba SED, Irunde H, Comoro C (2010) Barriers to ARV adherence among HIV/AIDS positive persons taking anti-retroviral therapy in two Tanzanian regions 8-12 months after program initiation. J AIDS Clinic Res 1: 111.

12Ntata PR (2007) Equity in access to ARV drugs in Malawi. Sahara J 4: 564-574.

13Bene M, Darkoh MB (2014) The constraints of antiretroviral uptake in rural areas: the case of Thamaga and surrounding villages, Botswana. Sahara J 11: 167- 177.

14Corbin J, Strauss A (1990) Grounded theory research: procedures, canons and evaluative criteria. Qualitative Sociology 13: 3-21.

15Jones PS (2012) Mind the gap: access to ARV medication, rights and the politics of scale in South Africa. Soc Sci Med 74: 28-35.

16Nam SL, Fielding K, Avalos A, Dickinson D, Gaolathe T, et al. (2008) The relationship of acceptance or denial of HIV-status to antiretroviral adherence among adult HIV patients in urban Botswana. Soc Sci Med 67: 301-310.

17Palar K, Martin A, Oropeza Camacho ML, Derose KP (2013) Livelihood experiences and adherence to HIV antiretroviral therapy among participants in a food assistance pilot in Bolivia: a qualitative study. PLoS One 8: e61935.

18Sodergard B, Halvarsson M, Sönnerborg A, Tully MP, Kettis A (2016) The degree of readiness among a population of HIV infected patients in Sweden. HIV Curr Res 1: 117.

19Patel S, Baxi RK, Patel SN, Golin CE, Mehta M, et al. (2012) Perceptions regarding barriers and facilitators to combination antiretroviral therapy adherence among people living with HIV/AIDS in Gujarat, India: a qualitative study. Indian J Sex Transm Dis 33: 107-111.

20Sigrid C, Jan C, Andy I (2007) Adherence to antiretroviral therapy A study of patient perspective and HIV. AIDS 21: 271-281.